(1) The acquisition of specific deregulated miRNAs is a newly discovered alternative mechanism developed by AI-resistant breast cancer cells to achieve constitutive activation of the AKT/mTOR pathway and to develop de novo or acquired resistance to AI. This evidence concerns the gene MTOR and breast carcinoma.